Diabetes drug shows promise in protecting kidneys: Study finds SGLT2 inhibitor canagliflozin helps oxygenate kidneys while causing glucose removal through urine
Read Full Article
#DiabetesResearch #KidneyHealth #SGLT2Inhibitors #Canagliflozin #HealthInnovation
Read Full Article
#DiabetesResearch #KidneyHealth #SGLT2Inhibitors #Canagliflozin #HealthInnovation
EurekAlert!
Diabetes drug shows promise in protecting kidneys
An Osaka Metropolitan University-led team evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that the drugs might help improve oxygenation in these organs.
Adults with overweight/obesity and type 2 diabetes who are given the SGLT-2 inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher rates of remission compared with calorie restriction alone
Read Full Article
#Type2Diabetes #WeightLossJourney #SGLT2Inhibitors #Dapagliflozin #HealthForAll
Read Full Article
#Type2Diabetes #WeightLossJourney #SGLT2Inhibitors #Dapagliflozin #HealthForAll
BMJ Group - Helping doctors make better decisions
SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission - BMJ Group
Study provides a practical strategy to achieve remission for adults with type 2 diabetes Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie…
❤3🐳1